NanoViricides, Inc.
NNVC · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $24,427 | $23,116 | $18,751 | $20,838 |
| - Cash | $1,125,711,000 | $1,559 | $2,543 | $3,958 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1,125,686,573 | $21,558 | $16,208 | $16,880 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$133 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,652 | -$1,935 | -$2,026 | -$1,831 |
| % Margin | – | – | – | – |
| Net Income | -$1,785 | -$2,096 | -$2,217 | -$2,027 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.13 | -0.14 | -0.14 |
| % Growth | 23.1% | 7.1% | 0% | – |
| Operating Cash Flow | -$1,594 | -$1,702 | -$1,991 | -$2,191 |
| Capital Expenditures | -$84 | -$10 | $0 | $0 |
| Free Cash Flow | -$1,678 | -$1,712 | -$1,991 | -$2,191 |